GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

StemGen SGNI · USD

N/A · US listing · 🇺🇸 United States

Compare

0.10

—

Close of 30 Oct 2026, in USD

StemGen annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In USD.

FY2021FY2020FY2019FY2018FY2017
Revenue$39,000$19,350$22,058——
Operating income−$244,000−$67,070−$243,000−$32,325$7,549
Net income−$433,000−$230,772−$426,000$6,115−$70,001
Free cash flow−$141,196−$36,525−$105,091−$8,135$7,547
Total assets$401,643$397,113$390,201—$635
Shareholders' equity−$1.3m−$1.1m−$869,799−$904,339−$910,454

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.